Cancer history, costs inhibit follow-up compliance among BI-RADS 3 patients

Thursday, October 10, 2019

A Breast Imaging Reporting and Data System (BI-RADS) 3 designation indicates there is between a 0% and 2% chance of cancer, for which physicians recommend six-month follow-up. Health Imaging (10/10) reports on a study published in the Journal of the American College of Radiology that found that just over half of patients completed their follow-up within the appropriate time frame.

MBI useful in particular breast screening scenarios

Tuesday, October 1, 2019

Aunt Minnie (10/1) reports that molecular breast imaging (MBI) is outperformed by mammography in most breast cancer screening scenarios, but it still belongs in the breast cancer screening arsenal, according to a literature review published in the new journal Radiology: Imaging Cancer.

Synthesized 2D mammography identifies smaller lesions

Monday, September 30, 2019

Aunt Minnie (9/30) reports that digital breast tomosynthesis (DBT) with synthesized 2D mammography identifies breast masses at smaller sizes than does full-field digital mammography (FFDM), according to a study published in Academic Radiology.

3T MRI feasible for deep brain stimulation patients

Wednesday, September 25, 2019

Aunt Minnie (9/25) reports that under certain parameters, 3-tesla MRI scans can be performed safely on patients undergoing deep brain stimulation (DBS) for neurological conditions, according to a study published in Radiology.

'Dramatic' survival increase with CDK4/6 inhibitor, new settings for immunotherapy, PFS gain with AKT inhibitor

Monday, September 23, 2019

Medpage Today (9/23) reports that atients with advanced hormone receptor (HR)-positive breast cancer obtained a first-ever survival improvement with a targeted agent as ribociclib (Kisqali) plus endocrine therapy led to a 24% absolute improvement over endocrine therapy alone, according to research presented at the American Society of Clinical Oncology (ASCO) meeting.